Search for: "Par Pharmaceutical Holdings, Inc."
Results 21 - 40
of 53
Sort by Relevance
|
Sort by Date
6 Aug 2013, 6:03 pm
Until questions about the security issues and their implications on the logon, password and other information associated with personal accounts are established, Americans concerned about the security of their personal information may want to hold off entering data in response to the HHS’s invitation. [read post]
30 Jul 2013, 2:01 pm
Lexis 1688, at *36) to Merrell Dow Pharmaceuticals, Inc. v. [read post]
7 Feb 2013, 10:50 am
Par Pharmaceutical, Inc., 694 F.3d 1344, 1351 (Fed. [read post]
2 Jan 2013, 11:54 am
Par Pharmaceutical (Sept. 28, 2012). [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
19 Apr 2012, 8:17 pm
AR Holding Co. [read post]
19 Oct 2011, 11:27 am
Prometheus Laboratories, Inc., the U.S. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
7 Sep 2011, 4:22 am
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]
5 Sep 2011, 9:36 pm
TWi Pharmaceuticals, Inc. 1:11-cv-02466; filed September 1, 2011 in the District Court of Maryland • Plaintiffs: Par Pharmaceutical, Inc.; EDT Pharma Holdings Ltd. [read post]
14 Aug 2011, 9:59 pm
Par Pharmaceutical Inc. et al. 1:11-cv-00705; filed August 10, 2011 in the District Court of Delaware • Plaintiffs: Avanir Pharmaceuticals Inc.; Avanir Holding Company; Center for Neurologic Study • Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
5 May 2011, 1:49 pm
., Inc., 2008 WL 4513696, at *5 (D.N.J. [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
27 Aug 2010, 2:41 pm
Ortho Pharmaceutical Corp., 209 Cal. [read post]
18 Aug 2010, 12:19 am
Par Pharmaceutical, Inc. et al. [read post]
14 Jun 2010, 6:12 pm
Par Pharm., Inc., 642 F. [read post]
2 Dec 2009, 11:05 am
On December 2, 2009, the FTC announced an order settling charges that Watson Pharmaceuticals, Inc. [read post]
12 Oct 2009, 12:38 pm
Citigroup Global Market, Inc. has filed a motion to dismiss an action against it by KV Pharmaceuticals Co. arising out of sales of auction rate securities, according to an August 25 article in Law360 by Christine Caufield entitled "Citigroup Argues KV Pharma Knew ARS Risks. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
